Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis c Genotype 1”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01715415
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 395
Large-scale testing (Phase 3)Study completedNCT01725529
What this trial is testing

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 457
Testing effectiveness (Phase 2)Study completedNCT01012895
What this trial is testing

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 215
Testing effectiveness (Phase 2)Study completedNCT00336479
What this trial is testing

Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 263
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01439373
What this trial is testing

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 16
Post-approval studies (Phase 4)Study completedNCT00356486
What this trial is testing

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 74
Large-scale testing (Phase 3)Study completedNCT02123654
What this trial is testing

UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 297
Large-scale testing (Phase 3)Study completedNCT01975675
What this trial is testing

Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 341
Testing effectiveness (Phase 2)Study completedNCT01058512
What this trial is testing

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 22
Not applicableStudy completedNCT01054742
What this trial is testing

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2
Testing effectiveness (Phase 2)Study completedNCT01628094
What this trial is testing

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT01343888
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 656
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Post-approval studies (Phase 4)UnknownNCT00370617
What this trial is testing

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Who this might be right for
Chronic Hepatitis CInsulin Resistance
University of Turin, Italy 200
Testing effectiveness (Phase 2)Study completedNCT01609933
What this trial is testing

Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study

Who this might be right for
Chronic Hepatitis C
AbbVie (prior sponsor, Abbott) 32
Testing effectiveness (Phase 2)Study completedNCT03501550
What this trial is testing

Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

Who this might be right for
Chronic Hepatitis C
Cocrystal Pharma, Inc. 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation